Predictors of ovarian cancer survival: a population-based prospective study in Sweden. 2008

Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom.

Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Little is known about reproductive factors or lifestyle determinants and ovarian cancer prognosis. The objective of this study was to examine whether ovarian cancer survival is influenced by reproductive history, anthropometric characteristics, prediagnostic life-style factors and family history of breast or ovarian cancer. The study population consisted of 635 epithelial ovarian cancer (EOC) cases derived from a nationwide population-based case-control study conducted in Sweden between 1993 and 1995. Exposure data on prediagnostic factors of interest were collected through questionnaires at the beginning of the parent study. Clinical data were abstracted from medical records. Cases were followed-up by means of record linkage to nationwide registers until December 31, 2002. Cox proportional hazard regression model was used to estimate the prognostic effect of each factor in terms of hazard ratios (HR) and 95% confidence intervals (CI), following adjustment for age at diagnosis, FIGO tumor stage and WHO grade of tumor differentiation. Tumor characteristics significantly influenced the risk of death from EOC. After adjustment for these, no clear associations were detected between reproductive history (parity, age at first or last birth, oral contraceptive use, age at menarche or menopause), anthropometric characteristics (body size and shape in different periods of life), lifestyle factors before diagnosis (alcohol consumption, smoking and physical activity over lifetime), nor family history of breast cancer or ovarian cancer and EOC survival. Our findings indicate that these prediagnostic factors do not influence the EOC survival. Nevertheless, among women with early stage disease (FIGO stage I and II), there was some indication that overweight in young adulthood or recent years increased the risk of death, while physical activity in young adult life appeared to reduce the risk of death due to EOC.

UI MeSH Term Description Entries
D008019 Life Style Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed) Lifestyle Factors,Life Style Induced Illness,Lifestyle,Factor, Lifestyle,Life Styles,Lifestyle Factor,Lifestyles
D008498 Medical Record Linkage The creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals. Record Linkage, Medical,Linkage, Medical Record,Linkages, Medical Record,Medical Record Linkages,Record Linkages, Medical
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001824 Body Constitution The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms. Body Constitutions,Constitution, Body,Constitutions, Body
D005260 Female Females

Related Publications

Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
February 1997, JAMA,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
February 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
January 2013, Epidemiology and health,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
May 1994, Journal of the National Cancer Institute,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
July 2011, The British journal of dermatology,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
February 2012, Cancer epidemiology,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
March 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
May 2005, Cancer causes & control : CCC,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
June 2018, Annals of epidemiology,
Ling Yang, and Asa Klint, and Mats Lambe, and Rino Bellocco, and Tomas Riman, and Kjell Bergfeldt, and Ingemar Persson, and Elisabete Weiderpass
September 2018, Annals of surgical oncology,
Copied contents to your clipboard!